care and emergency medical workers is a significant advance," according to infectious disease specialist Harmony Tyner. The New York Times (3/29, Kolata, 20.6M) reports, "Consistent with clinical trial data, a two-dose regimen prevented 90 percent of infections by two weeks after the second shot. One